New 2026–2029 Framework Agreement on Medicine Supply Faces Immediate Global Challenges
A new 2026–2029 Framework Agreement addresses Ireland's medicine shortages, acknowledging the need for engineered supply security. However, global disruptions, including rising costs and geopolitical conflicts, are immediately testing its effectiveness. The agreement's current mechanisms are proving insufficient against intensifying external pressures, highlighting the need for more proactive and adaptable solutions.
Medicine shortages, long dismissed as anecdotal, are a growing concern, impacting patients needing epilepsy, ADHD, and cancer medications. Pharmacists spend hours sourcing alternatives due to supply chain vulnerabilities, particularly reliance on single-source medicines.
The Medicine Shortages Index (late 2022) and a subsequent White Paper highlighted the need for systemic solutions, including an essential medicines list, stronger supplier resilience, faster regulatory pathways, and pricing tools. This led to the 2026–2029 Framework Agreement on the Supply and Pricing of Medicines, the first national State–industry agreement recognizing the need to engineer supply security.
However, weeks into its life, the agreement faces immediate tests from global disruptions. Higher tariffs and Middle East conflict have destabilized freight routes and surged energy prices. Active pharmaceutical ingredient costs are up by as much as 60 percent. Ireland, a smaller, price-sensitive market, is vulnerable, as economic assumptions underpinning the agreement are already undercut.
The agreement's measures, like urgent pricing uplifts and a 1.5 percent annual value maintenance realignment, are proving insufficient against these pressures. Their narrow scope and slow decision-making limit their effectiveness. While provisions for shortage notification improve visibility, they lack stronger preventive measures like stockholding requirements. The system's tendency to react rather than anticipate remains a concern, necessitating further adaptation beyond the current framework.